Back to search

GPCR functional selectivity has therapeutic impact

Data up to Jan 2025

Published2007
Citations204
References58

Total Citations Per Year

Abstract

References (58)

Multiple receptors for dopamine

1979 • 3,739 citations

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1976 • 2,224 citations

Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain

1963 • 2,148 citations

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system

1970 • 1,980 citations

Society for Neuroscience Abstracts

1997 • 1,445 citations

A MODIFICATION OF RECEPTOR THEORY

1956 • 1,126 citations

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

2006 • 1,076 citations

Pharmacologic Analysis of Drug Receptor Interaction

1988 • 936 citations

Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology

2003 • 918 citations

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

2002 • 896 citations

The central effects of a novel dopamine agonist

1978 • 646 citations

Advances in Drug Research

1964 • 615 citations

Interactions of the Novel Antipsychotic Aripiprazole (OPC-14597) with Dopamine and Serotonin Receptor Subtypes

1999 • 407 citations

Dopamine Partial Agonists

2004 • 321 citations

7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.

1995 • 268 citations

The Dopamine Receptors

1997 • 260 citations

Pharmacologic analysis of drug-receptor interaction

1995 • 255 citations

Schizophrenic Symptoms Improve with Apomorphine

1978 • 228 citations

Affinity and intrinsic activity in the theory of competitive inhibition. I. Problems and theory.

1954 • 216 citations

Dopamine receptors: Pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum

1978 • 203 citations

Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways

2006 • 188 citations

Trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist

1990 • 171 citations

Dopamine D2 and D3 receptors inhibit dopamine release.

1994 • 149 citations

Partial dopamine agonists in the treatment of psychosis

2002 • 147 citations

"Dopamine System Stabilizers, Aripiprazole, and the Next Generation of Antipsychotics, Part 1: "Goldilocks" Actions at Dopamine Receptors

2001 • 138 citations

Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-ioduced parkinsonism in monkeys

1991 • 137 citations

Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist

1991 • 135 citations

Open‐label flexible‐dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease

2006 • 134 citations

Relationship between receptor occupancy and response at striatal dopamine autoreceptors.

1987 • 133 citations

Functional Selectivity of Dopamine Receptor Agonists. I. Selective Activation of Postsynaptic Dopamine D2Receptors Linked to Adenylate Cyclase

2002 • 121 citations

Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis

2002 • 116 citations

[Therapeutic method derived from hiberno-therapy in excitation and agitation states].

1952 • 112 citations

Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia

1998 • 107 citations

Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist

1989 • 106 citations

Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.

1992 • 100 citations

Dopamine Agonist Treatment of Schizophrenia With N-Propylnorapomorphine

1986 • 95 citations

Effect of apomorphine on schizophrenic symptoms

1977 • 88 citations

Functional Selectivity of D2Receptor Ligands in a Chinese Hamster Ovary hD2LCell Line: Evidence for Induction of Ligand-Specific Receptor States

2004 • 86 citations

Functional Selectivity of Dopamine Receptor Agonists. II. Actions of Dihydrexidine in D2LReceptor-Transfected MN9D Cells and Pituitary Lactotrophs

2002 • 82 citations

Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors.

1996 • 80 citations

Conformational Analysis of D1 Dopamine Receptor Agonists: Pharmacophore Assessment and Receptor Mapping

1996 • 65 citations

Parkinson's disease and D1 dopamine receptors.

2001 • 62 citations

Drugs and Receptors

1990 • 51 citations

Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands

1989 • 50 citations

Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist.

1991 • 48 citations

Effect of D1 receptor stimulation in normal and MPTP monkeys

1989 • 46 citations

Pharmacologic properties of (?)-3PPP (preclamol) in man

1992 • 41 citations

Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands

1988 • 39 citations

The use of dopamine agonists in the treatment of schizophrenia.

1981 • 37 citations

A MODIFICATION OF RECEPTOR THEORY

1997 • 32 citations

Dopamine D1 and D2 receptor interactions in the MPTP-treated marmoset

1992 • 31 citations

A modification of receptor theory

1997 • 30 citations

Functional Selectivity, Ligand-Directed Trafficking, Conformation-Specific Agonism: What's In A Name?

2005 • 26 citations

Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist

1997 • 24 citations

Dopamine receptor subtypes : from basic science to clinical application

1998 • 24 citations

The Development of Novel Dopamine Agonists

1983 • 22 citations

Molecular Drug Design and Dopamine Receptors

1997 • 15 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
GPCR functional selectivity has therapeutic impact (2007) – Trends in Pharmacological Sciences | Metascience Observatory Explorer